TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.
TargED Biopharmaceuticals has raised $25.3M in total funding. The most recent round was Series A. The last funding was announced in December 2025.
TargED Biopharmaceuticals's investors include Andera Partners, BioGeneration Ventures, Inkef, Hadean Ventures, Sunstone Life Science Ventures.
TargED Biopharmaceuticals is headquartered in Utrecht, The Netherlands.
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.
TargED Biopharmaceuticals is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TargED Biopharmaceuticals — Funding & Investors." VCBacked, December 16, 2025, https://www.vcbacked.co/company/targed-biopharmaceuticals. Accessed August 14, 2026.
VCBacked. (2025). TargED Biopharmaceuticals — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/targed-biopharmaceuticals
{{cite web |title=TargED Biopharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/targed-biopharmaceuticals |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated